CD44 and hepatocellular carcinoma: A report stated that high cholesterol levels enhance the lipid raft localization of CD44 in a palmitoylation‐dependent manner, and disrupts CD44‐Ezrin binding, ultimately reducing HCC cell migration and metastasis [96] (Fig. 2, Table 1).